Lipoprotein metabolism in familial hypercholesterolemia

Area of Science:

• Lipid metabolism and cardiovascular disease research.

Background:

• Familial hypercholesterolemia (FH) is a genetic disorder characterized by high cholesterol levels.
• Low-density lipoprotein (LDL) receptor deficiency is a primary cause of homozygous FH.
• Apolipoprotein B (apo B)-containing lipoproteins are central to lipid transport and cardiovascular risk.

Purpose of the Study:

• To investigate the metabolic disturbances in apolipoprotein B-containing lipoproteins in homozygous familial hypercholesterolemia.
• To elucidate the impact of LDL receptor deficiency on lipoprotein metabolism and clearance.

Main Methods:

• Analysis of plasma lipoprotein profiles in patients with homozygous FH.
• Assessment of apolipoprotein B metabolism, including synthesis and clearance rates.
• Characterization of lipoprotein particle delipidation cascade.

Main Results:

• Homozygous FH exhibits a significant accumulation of plasma LDL and less dense VLDL and IDL particles.
• Apo B oversynthesis and impaired clearance contribute to lipoprotein accumulation.
• The largest VLDL subfraction is unaffected, while particle transit time is prolonged.

Conclusions:

• LDL receptor deficiency profoundly disrupts apo B-lipoprotein metabolism.
• Impaired clearance and prolonged residence time of apo B particles increase atherosclerosis risk.
• Understanding these mechanisms is crucial for managing FH and preventing atherosclerosis.